AlphaHelix Molecular Diagnostics AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 8.4 million compared to SEK 13.11 million a year ago. Revenue was SEK 8.48 million compared to SEK 13.23 million a year ago.

Net loss was SEK 0.554 million compared to net income of SEK 1.42 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to basic earnings per share from continuing operations of SEK 0.02 a year ago.